AIRLINK 159.70 Increased By ▲ 4.74 (3.06%)
BOP 10.04 Increased By ▲ 0.13 (1.31%)
CNERGY 7.80 Increased By ▲ 0.43 (5.83%)
CPHL 83.41 Increased By ▲ 0.50 (0.6%)
FCCL 48.50 Increased By ▲ 0.64 (1.34%)
FFL 15.08 Increased By ▲ 0.40 (2.72%)
FLYNG 49.46 Increased By ▲ 4.50 (10.01%)
HUBC 141.80 Increased By ▲ 3.83 (2.78%)
HUMNL 12.75 Decreased By ▼ -0.12 (-0.93%)
KEL 4.47 Increased By ▲ 0.18 (4.2%)
KOSM 5.33 Increased By ▲ 0.17 (3.29%)
MLCF 76.00 Increased By ▲ 0.69 (0.92%)
OGDC 213.65 Increased By ▲ 0.98 (0.46%)
PACE 5.33 Increased By ▲ 0.18 (3.5%)
PAEL 47.04 Increased By ▲ 0.91 (1.97%)
PIAHCLA 17.13 Increased By ▲ 0.85 (5.22%)
PIBTL 8.86 Increased By ▲ 0.29 (3.38%)
POWER 15.10 Decreased By ▼ -0.08 (-0.53%)
PPL 173.75 Increased By ▲ 3.84 (2.26%)
PRL 33.69 Increased By ▲ 2.55 (8.19%)
PTC 22.06 Increased By ▲ 2.01 (10.02%)
SEARL 83.95 Increased By ▲ 0.18 (0.21%)
SSGC 37.14 Increased By ▲ 1.07 (2.97%)
SYM 15.48 Increased By ▲ 0.58 (3.89%)
TELE 7.55 Increased By ▲ 0.34 (4.72%)
TPLP 8.59 Increased By ▲ 0.17 (2.02%)
TRG 65.00 Decreased By ▼ -1.20 (-1.81%)
WAVESAPP 9.29 Increased By ▲ 0.34 (3.8%)
WTL 1.28 Increased By ▲ 0.03 (2.4%)
YOUW 3.74 Increased By ▲ 0.14 (3.89%)
BR100 12,894 Increased By 223.7 (1.77%)
BR30 38,175 Increased By 807.9 (2.16%)
KSE100 119,962 Increased By 1425.4 (1.2%)
KSE30 36,773 Increased By 479.3 (1.32%)

BioNTech

Malaysia says its delivery of Pfizer vaccines on track
World

Malaysia says its delivery of Pfizer vaccines on track

  • The Pfizer vaccine is produced in Belgium and the European Commission said on Friday it had agreed a plan to control exports of vaccines from the European Union, including to Britain.
  • With the assurances of both the EU and Belgian Ambassadors, the COVID-19 immunisation plan is expected to proceed according to plan.
Published 02 Feb, 2021 06:25pm
J&J's COVID-19 vaccine 66pc effective in large global trial
Business & Finance

J&J's COVID-19 vaccine 66pc effective in large global trial

  • A high bar has been set by two authorized vaccines from Pfizer/BioNTech and Moderna, which were around 95% effective in preventing symptomatic illness in pivotal trials when given in two doses.
  • J&J's main goal was the prevention of moderate to severe COVID-19, and the vaccine was 85% effective in stopping severe disease.
Published 29 Jan, 2021 07:16pm
Pakistan likely to receive Pfizer-BioNTech vaccine under COVAX programme
Pakistan

Pakistan likely to receive Pfizer-BioNTech vaccine under COVAX programme

  • The WHO signed an advance purchase agreement with the American pharmaceutical, where it will receive at least 40 million doses of the drug.
  • It also anticipates another 50 million doses from UK-based pharmaceutical Oxford-Astrazeneca. As per the existing agreement with the company, the shipment will be made in first quarter of the year.
Published 26 Jan, 2021 05:09pm